These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 9834941)

  • 81. Anti-Oxidants as Chemopreventive Agents in Prostate Cancer: A Gap Between Preclinical and Clinical Studies.
    Mohsenzadegan M; Seif F; Farajollahi MM; Khoshmirsafa M
    Recent Pat Anticancer Drug Discov; 2018; 13(2):224-239. PubMed ID: 29446748
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Apoptosis as a novel target for cancer chemoprevention.
    Sun SY; Hail N; Lotan R
    J Natl Cancer Inst; 2004 May; 96(9):662-72. PubMed ID: 15126603
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Diapolycopenedioic-acid-diglucosyl ester and keto-myxocoxanthin glucoside ester: Novel carotenoids derived from Exiguobacterium acetylicum S01 and evaluation of their anticancer and anti-inflammatory activities.
    Jinendiran S; Dahms HU; Dileep Kumar BS; Kumar Ponnusamy V; Sivakumar N
    Bioorg Chem; 2020 Oct; 103():104149. PubMed ID: 32861993
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer Institute.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():55-62. PubMed ID: 7616753
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Evaluation for safety of antioxidant chemopreventive agents.
    Kawanishi S; Oikawa S; Murata M
    Antioxid Redox Signal; 2005; 7(11-12):1728-39. PubMed ID: 16356133
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Use of intermediate endpoints in quantitating the response of precancerous lesions to chemopreventive agents.
    Rosin MP; Dunn BP; Stich HF
    Can J Physiol Pharmacol; 1987 Mar; 65(3):483-7. PubMed ID: 3555753
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Chemoprevention of lung cancer: current status and future prospects.
    Cohen V; Khuri FR
    Cancer Metastasis Rev; 2002; 21(3-4):349-62. PubMed ID: 12549771
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Chemoprevention of oral cancer: A review and future perspectives.
    Liao YH; Chou WY; Chang CW; Lin MC; Wang CP; Lou PJ; Chen TC
    Head Neck; 2023 Apr; 45(4):1045-1059. PubMed ID: 36810813
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Oral cancer inhibition by micronutrients. The experimental basis for clinical trials.
    Shklar G; Schwartz J
    Eur J Cancer B Oral Oncol; 1993 Jan; 29B(1):9-16. PubMed ID: 8180584
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The failure of cancer chemoprevention.
    Potter JD
    Carcinogenesis; 2014 May; 35(5):974-82. PubMed ID: 24618374
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Carotenoids in the treatment of diabetes mellitus and its complications: A mechanistic review.
    Roohbakhsh A; Karimi G; Iranshahi M
    Biomed Pharmacother; 2017 Jul; 91():31-42. PubMed ID: 28445831
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Antioxidant Vitamins and Beta-Carotene in Disease Prevention. Proceedings of a symposium. Berlin, Germany, October 10-12, 1994.
    Am J Clin Nutr; 1995 Dec; 62(6 Suppl):1299S-1540S. PubMed ID: 7495223
    [No Abstract]   [Full Text] [Related]  

  • 93. Vitamins and carotenoids--a promising approach to reducing the risk of coronary heart disease, cancer and eye diseases.
    Schalch W; Weber P
    Adv Exp Med Biol; 1994; 366():335-50. PubMed ID: 7771264
    [No Abstract]   [Full Text] [Related]  

  • 94. Carotenoids as chemopreventive agents.
    Krinsky NI
    Prev Med; 1989 Sep; 18(5):592-602. PubMed ID: 2694157
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Manipulation of nutrients to prevent cancer.
    Greenwald P
    Hosp Pract (Off Ed); 1984 May; 19(5):119-21, 124-6, 131-4. PubMed ID: 6425329
    [No Abstract]   [Full Text] [Related]  

  • 96. Concepts in cancer chemoprevention research.
    Greenwald P; Nixon DW; Malone WF; Kelloff GJ; Stern HR; Witkin KM
    Cancer; 1990 Apr; 65(7):1483-90. PubMed ID: 2178765
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Carotenoids for lung cancer chemoprevention and chemotherapy: Promises and controversies.
    Varghese R; Efferth T; Ramamoorthy S
    Phytomedicine; 2023 Jul; 116():154850. PubMed ID: 37187036
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A new direction in preventive oncology: chemoprevention.
    Olsen SJ; Love RR
    Semin Oncol Nurs; 1986 Aug; 2(3):211-21. PubMed ID: 3529275
    [No Abstract]   [Full Text] [Related]  

  • 99. The biologic basis for the use of retinoids in cancer prevention and treatment.
    Kurie JM
    Curr Opin Oncol; 1999 Nov; 11(6):497-502. PubMed ID: 10550014
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Immune cells in the tumour: new routes of retinoids for chemoprevention and chemotherapeutics.
    Jiang L; Dong R; Ying M; He Q; Cao J; Yang B
    Br J Pharmacol; 2018 Dec; 175(23):4285-4294. PubMed ID: 30298911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.